ProQR Therapeutics NV (PRQR)
2.365
-0.06
(-2.67%)
USD |
NASDAQ |
Aug 25, 16:00
2.365
0.00 (0.00%)
After-Hours: 19:38
ProQR Therapeutics Market Cap : 333.75M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 342.93M |
| August 21, 2026 | 330.22M |
| August 20, 2026 | 320.35M |
| August 19, 2026 | 313.29M |
| August 18, 2026 | 303.41M |
| August 17, 2026 | 272.36M |
| August 14, 2026 | 270.95M |
| August 13, 2026 | 261.07M |
| August 12, 2026 | 262.49M |
| August 11, 2026 | 270.95M |
| August 10, 2026 | 190.71M |
| August 07, 2026 | 197.55M |
| August 06, 2026 | 200.19M |
| August 05, 2026 | 207.56M |
| August 04, 2026 | 192.81M |
| August 03, 2026 | 180.17M |
| July 31, 2026 | 181.22M |
| July 30, 2026 | 187.55M |
| July 29, 2026 | 182.28M |
| July 28, 2026 | 185.44M |
| July 27, 2026 | 182.28M |
| July 24, 2026 | 181.22M |
| July 23, 2026 | 188.60M |
| July 22, 2026 | 190.71M |
| July 21, 2026 | 198.08M |
| Date | Value |
|---|---|
| July 20, 2026 | 185.44M |
| July 17, 2026 | 179.12M |
| July 16, 2026 | 175.96M |
| July 15, 2026 | 186.49M |
| July 14, 2026 | 179.12M |
| July 13, 2026 | 179.12M |
| July 10, 2026 | 182.28M |
| July 09, 2026 | 185.44M |
| July 08, 2026 | 177.01M |
| July 07, 2026 | 174.90M |
| July 06, 2026 | 181.22M |
| July 02, 2026 | 190.71M |
| July 01, 2026 | 184.38M |
| June 30, 2026 | 195.97M |
| June 29, 2026 | 192.81M |
| June 26, 2026 | 161.20M |
| June 25, 2026 | 164.89M |
| June 24, 2026 | 190.71M |
| June 23, 2026 | 199.14M |
| June 22, 2026 | 198.08M |
| June 18, 2026 | 199.14M |
| June 17, 2026 | 175.96M |
| June 16, 2026 | 160.15M |
| June 15, 2026 | 164.37M |
| June 12, 2026 | 151.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pharming Group NV | 846.51M |
| NewAmsterdam Pharma Co. NV | 3.214B |
| argenx SE | 63.09B |
| Mirum Pharmaceuticals, Inc. | 6.352B |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
Market Cap Related Metrics
| PS Ratio | 11.71 |
| PEG Ratio | -1.114 |
| Price to Book Value | 3.673 |
| Price | 2.365 |
| Earnings Yield | -19.61% |
| PEGY Ratio | -1.114 |